Clinical Trial Update: SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era

View source ↗

Summary

SCOPE is an observational study investigating the consequences of the protease inhibitor era in HIV infection. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV Infections | Status: RECRUITING